Adrenocorticotropin-secreting PAs (ACTH-PAs, 3%-6%) and thyrotropin-secreting PAs (TSH-PAs, <1%) can cause obvious clinical symptoms, but their incidence is lower than that of PRL-PAs and GH-PAs [2, 5, 6]. This evidence concerns the gene PRL and gonorrhea.